this report concerns a determinate series of 11 patients with progressive recurrent cancer of the cervix uteri , who were treated with misonidazole ( 1 g ) applied locally for 24 hours and an oral dose of 2.9 g/m2 four hours before a single mid-plane dose of 5.00 gy .
C0278579
recurrent cancer of the cervix
C0042149
uteri